Investing in the future of healthcare

17.5VC is a specialist fund-of-funds investing in the next generation of healthcare innovation. We connect accredited investors to exceptional, difficult-to-access venture capital funds driving breakthroughs in diagnostics, digital health, biotech, and med-tech, deliver diversified exposure, professional diligence, and institutional-grade strategy at a private scale.

WHAT WE DELIVER TO INVESTORS

Exclusive Access

17.5VC opens doors to top-tier healthcare venture capital funds usually closed to individual investors, providing entry to high-potential deals.

Diversified Exposure

Our FoF offers access to hundreds of startups across sectors, stages, and regions – reducing risk and improving return potential.

Institutional-Grade Management

Investors benefit from professional portfolio management and due diligence without requiring large capital commitments.

Co-Investment Opportunities

17.5VC offers the chance to co-invest alongside leading VCs in select high-growth companies, amplifying potential returns.

PARTNERING WITH TOP VC MANAGERS

17.5VC's curated portfolio aims for resilience and outperformance by balancing four critical dimensions of venture capital allocation.

Sector Focused

We invest across healthcare sectors—health-tech, biotech, med-tech, diagnostics and digital therapeutics—to capture both near-term adoption and long-term breakthroughs.

Global Reach

Our geographic spread spans top global innovation hubs, ensuring exposure to diverse regulatory and market dynamics.

Multistaged

We emphasize early and mid-stage funds while maintaining targeted seed and growth exposure to optimize returns and manage risk.

Specialized GPs

We focus on small-to-mid-sized specialist funds that outperform larger peers, offering stronger founder alignment, better deal access, and exposure to top-tier venture opportunities.

TEAM

David Nichtenhauser

FOUNDING PARTNER

A seasoned investment professional with over 25 years of experience in portfolio management, asset allocation, and investment due diligence. Former Portfolio Manager and Executive Committee Member at the Abu Dhabi Investment Authority (ADIA), where he oversaw a $5 billion portfolio of alternative investments. Previously held senior investment roles at ABN Amro and LGT Capital Partners, focused on manager selection, due diligence, and portfolio construction for institutional fund-of-funds platforms. He holds a bachelor of science degree in applied economics from Cornell University.

Dr. Shaun Kuan

FOUNDING PARTNER

A physician-turned-venture investor with over a decade of experience spanning clinical practice, product leadership, and healthtech entrepreneurship across Asia. Most recently served as Chief Product Officer at a PE-backed diagnostics and digital health company operating in nine countries, leading product strategy across clinical, lab, and enterprise systems at national scale. Previously a founding executive at NADI Health and co-founder of Savor of Life. Active investor and advisor to healthtech ventures including VentureBlick and QmedAsia. Certified lifestyle medicine physician and Harvard Medical School Metabolic Health program graduate.